390 related articles for article (PubMed ID: 16630403)
41. Neoadjuvant chemotherapy of cisplatin and fluorouracil regimen in head and neck squamous cell carcinoma: a meta-analysis.
Su YX; Zheng JW; Zheng GS; Liao GQ; Zhang ZY
Chin Med J (Engl); 2008 Oct; 121(19):1939-44. PubMed ID: 19080128
[TBL] [Abstract][Full Text] [Related]
42. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china.
Chen Y; Liu MZ; Liang SB; Zong JF; Mao YP; Tang LL; Guo Y; Lin AH; Zeng XF; Ma J
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1356-64. PubMed ID: 18472356
[TBL] [Abstract][Full Text] [Related]
43. Cutaneous squamous cell carcinoma metastatic to parotid-area lymph nodes.
Hinerman RW; Indelicato DJ; Amdur RJ; Morris CG; Werning JW; Vaysberg M; Kirwan J; Mendenhall WM
Laryngoscope; 2008 Nov; 118(11):1989-96. PubMed ID: 18849863
[TBL] [Abstract][Full Text] [Related]
44. Modified radical neck dissection and minimal invasive tumor surgery in the middle of split course of concomitant chemoradiotherapy of advanced HNSCC.
Schwentner I; Schmutzhard J; Andrle J; Haidenberger A; Thumfart WF; De Vries A; Sprinzl GM
Auris Nasus Larynx; 2007 Mar; 34(1):85-9. PubMed ID: 17074457
[TBL] [Abstract][Full Text] [Related]
45. Multimodal intensification regimens for advanced, resectable, previously untreated squamous cell cancer of the oral cavity, oropharynx, or hypopharynx: a 12-year experience.
Schuller DE; Ozer E; Agrawal A; Grecula JC; Rhoades CA; Young DC
Arch Otolaryngol Head Neck Surg; 2007 Apr; 133(4):320-6. PubMed ID: 17438244
[TBL] [Abstract][Full Text] [Related]
46. Feasibility and efficacy of accelerated weekly concomitant boost postoperative radiation therapy combined with concomitant chemotherapy in patients with locally advanced head and neck cancer.
Pehlivan B; Luthi F; Matzinger O; Betz M; Dragusanu D; Bulling S; Bron L; Pasche P; Seelentag W; Mirimanoff RO; Zouhair A; Ozsahin M
Ann Surg Oncol; 2009 May; 16(5):1337-43. PubMed ID: 19280263
[TBL] [Abstract][Full Text] [Related]
47. Squamous cell carcinoma from an unknown head and neck primary site: a "selective treatment" approach.
Patel RS; Clark J; Wyten R; Gao K; O'Brien CJ
Arch Otolaryngol Head Neck Surg; 2007 Dec; 133(12):1282-7. PubMed ID: 18086973
[TBL] [Abstract][Full Text] [Related]
48. Feasibility study of single agent Cisplatin and concurrent radiotherapy in Japanese patients with squamous cell carcinoma of the head and neck: preliminary results.
Zenda S; Onozawa Y; Tahara M; Kawashima M; Shikama N; Sasaki S; Boku N
Jpn J Clin Oncol; 2007 Oct; 37(10):725-9. PubMed ID: 17925299
[TBL] [Abstract][Full Text] [Related]
49. Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma.
Hassan KA; Ang KK; El-Naggar AK; Story MD; Lee JI; Liu D; Hong WK; Mao L
Cancer Res; 2002 Nov; 62(22):6414-7. PubMed ID: 12438226
[TBL] [Abstract][Full Text] [Related]
50. Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinoma.
Nuyts S; Dirix P; Clement PM; Poorten VV; Delaere P; Schoenaers J; Hermans R; Van den Bogaert W
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1088-95. PubMed ID: 18707823
[TBL] [Abstract][Full Text] [Related]
51. Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathologic residual carcinoma and prognosis.
Lango MN; Andrews GA; Ahmad S; Feigenberg S; Tuluc M; Gaughan J; Ridge JA
Head Neck; 2009 Mar; 31(3):328-37. PubMed ID: 18853450
[TBL] [Abstract][Full Text] [Related]
52. Concomitant radiochemotherapy in primary inoperable advanced head and neck cancer with 5-fluorouracil and mitomycin-C.
Christiansen H; Hermann RM; Hille A; Weiss E; Nitsche M; Martin A; Hess CF; Pradier O
Head Neck; 2004 Oct; 26(10):845-53. PubMed ID: 15390205
[TBL] [Abstract][Full Text] [Related]
53. Predictors and patterns of recurrence after definitive chemoradiation for anal cancer.
Das P; Bhatia S; Eng C; Ajani JA; Skibber JM; Rodriguez-Bigas MA; Chang GJ; Bhosale P; Delclos ME; Krishnan S; Janjan NA; Crane CH
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):794-800. PubMed ID: 17379452
[TBL] [Abstract][Full Text] [Related]
54. Multicenter validation of recursive partitioning analysis classification for patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy.
Jonkman A; Kaanders JH; Terhaard CH; Hoebers FJ; van den Ende PL; Wijers OB; Verhoef LC; de Jong MA; Leemans CR; Langendijk JA
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):119-25. PubMed ID: 17448870
[TBL] [Abstract][Full Text] [Related]
55. Accelerated versus conventional fractionated postoperative radiotherapy for advanced head and neck cancer: results of a multicenter Phase III study.
Sanguineti G; Richetti A; Bignardi M; Corvo' R; Gabriele P; Sormani MP; Antognoni P
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):762-71. PubMed ID: 15708255
[TBL] [Abstract][Full Text] [Related]
56. Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
Katori H; Tsukuda M; Watai K
Cancer Chemother Pharmacol; 2007 Aug; 60(3):399-406. PubMed ID: 17096160
[TBL] [Abstract][Full Text] [Related]
57. Outcomes of patients with n3 neck nodes treated with chemoradiation.
Ballonoff A; Raben D; Rusthoven KE; Bassetti M; Kane M; Song JI; Chen C
Laryngoscope; 2008 Jun; 118(6):995-8. PubMed ID: 18364595
[TBL] [Abstract][Full Text] [Related]
58. Results of postoperative reirradiation for recurrent or second primary head and neck carcinoma.
Kasperts N; Slotman BJ; Leemans CR; de Bree R; Doornaert P; Langendijk JA
Cancer; 2006 Apr; 106(7):1536-47. PubMed ID: 16518815
[TBL] [Abstract][Full Text] [Related]
59. Postoperative radiotherapy for insecure or positive surgical margins in head and neck cancer.
Ampil FL; Caldito G; Ghali GE; Nathan CO
J Oral Maxillofac Surg; 2003 Apr; 61(4):425-9. PubMed ID: 12684958
[TBL] [Abstract][Full Text] [Related]
60. Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: long-term results of phase III clinical trial.
Skladowski K; Maciejewski B; Golen M; Tarnawski R; Slosarek K; Suwinski R; Sygula M; Wygoda A
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):706-13. PubMed ID: 17011446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
